Simulations Plus
Lancaster, CA · United States
Specialization: ADMET / PBPK Software
Key Differentiator
NASDAQ: SLP; only independent publicly-traded biosimulation company; GastroPlus = gold standard for oral absorption prediction; expanded into AI-driven training (2024-2025)
Core Services
GastroPlus (PBPK absorption modeling), ADMET Predictor, MembranePlus, MonolixSuite (popPK), PKPlus, DDDPlus (drug dissolution), AI-driven training platforms
Capabilities
Market Intelligence
Biosimulation software = 60-65% of market revenue; growing regulatory mandate for MIDD (FDA MIPD program)
Website
https://simulations-plus.comNeed help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.